The longevity biomarker panel: markers clinicians track

A plain-English tour of the blood tests that show up on most longevity panels — and what the research actually links them to.

TL;DR

A longevity biomarker panel is a set of blood tests that track the systems most likely to decline with age. It usually blends heart, blood-sugar, inflammation, and hormone markers. No single number predicts a long life. The value is the trend over time, read with a clinician.

What a longevity biomarker panel is

A longevity biomarker panel is a curated group of blood tests picked to reflect age-related risk. Think of it like the warning lights on a car dashboard. Each light watches a different system. Common markers include ApoB (apolipoprotein B, a count of harmful cholesterol particles), hs-CRP (high-sensitivity C-reactive protein, an inflammation signal), HbA1c (a three-month blood-sugar average), fasting insulin, and IGF-1 (insulin-like growth factor 1, a hormone tied to growth signaling).

How it works

Each marker is a proxy — a stand-in measurement — for a process you cannot see directly. ApoB counts the particles that can lodge in artery walls. HbA1c reflects how much sugar has coated your red blood cells over roughly three months. hs-CRP rises when the body runs a low, steady level of inflammation. Read together, these numbers sketch how well the major systems are holding up.

Who asks about it

People come to this topic when a birthday, a family history, or a wearable nudges them to ask a bigger question. They want to know which biomarkers predict healthy aging, not just whether today’s result is “normal.” The interest is proactive: catch a trend early, while there is still time to act.

What the research says

The evidence supports individual markers more than any bundled “longevity score.” An HbA1c of 5.7 to 6.4 percent signals prediabetes, an early metabolic warning (CDC, 2024). ApoB predicts cardiovascular risk at least as well as standard LDL cholesterol, and often better (Sniderman et al., JAMA Cardiology, 2019). Higher hs-CRP is linked to greater cardiovascular risk in large population studies (NIH MedlinePlus, 2023). These are associations, not certainties.

What to know before considering it

A panel describes risk; it does not diagnose disease or dictate treatment. Numbers drift with illness, sleep, and stress, so one odd value is rarely meaningful. Ordering and interpreting these labs, and deciding on any next step, requires a licensed clinician who knows your history.

The Halftime POV

We see biomarkers as a conversation starter, not a scoreboard. The point of the second half of life is to act on good information early. A thoughtful panel, read as a trend and paired with a clinician, beats chasing a single number.

Related reading:

• Biomarkers 101: the foundation
• How biomarkers work
• Who should test, and when
• Which biomarkers to track on a peptide protocol

FAQ

What is a longevity biomarker panel? It is a group of blood tests chosen to reflect the systems that tend to fail with age: heart, blood sugar, inflammation, and hormones. Common markers are ApoB, hs-CRP, HbA1c, fasting insulin, and IGF-1. It tracks trends; it is not a diagnosis on its own.

Which biomarkers predict healthy aging? No single test does. Panels combine cardiovascular markers (ApoB, hs-CRP), metabolic markers (HbA1c, fasting insulin), and a hormonal marker (IGF-1). Each links to age-related risk in the literature, but describes risk, not destiny.

What labs should I track for longevity? Most panels include ApoB, hs-CRP, HbA1c, fasting glucose and insulin, a lipid panel, and IGF-1, plus kidney and liver basics. A licensed clinician should tailor the exact set to you.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Want to know when Halftime Health launches lab-guided care? Join the waitlist for updates.

Sources

• Centers for Disease Control and Prevention. “Prediabetes and Your A1C Test.” CDC, 2024. https://www.cdc.gov/diabetes/diabetes-testing/prediabetes-a1c-test.html
• Sniderman AD, et al. “Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.” JAMA Cardiology, 2019.
• U.S. National Library of Medicine. “C-Reactive Protein (CRP) Test.” MedlinePlus, 2023. https://medlineplus.gov/lab-tests/c-reactive-protein-crp-test/